Synthetic Biology

Like any engineering cycle Synthetic Biology goes through developing specifications.

SYNBIOSAFE is a project in Europe to research the safety and ethical aspects of synthetic biology, and aims to proactively stimulate a debate on these issues.

This article by Denise Caruso of The Hybrid Vigor Institute discusses a lengthy list of potential risks, as well as broad scientific and social concerns,in the field of synthetic biology.

With these benefits increasing demand for industrial biotechnology products and processes, this study uses patent data, survey results, and technology and firm level data from emerging sectors of industrial biotechnology to paint a detailed picture of innovation in the field. 

We have used the biological processes of microorganisms for 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

It shows the application of industrial biotechnology can improve the efficiency of the biofuel and renewable chemical industries and gives an understanding of the impact of industrial biotechnology on the U.S. economy up to 2008. 

Today, the biotechnology industry is enjoying more success and influence than ever before. Our industry’s innovations continue to improve the lives of people worldwide, and the advancement of these innovations is supported by the work of BIO.

Biotechnology, the combination of biology and technology, includes biologic applications, diagnostic tools and businesses that improve everyday life by providing solutions to some of life's most vexing problems.

A comic-style explanation of Synthetic Biology that appeared in Nature.

August 27 2012
We are writing to caution against granting a waiver for the federal Renewable Fuel Standard (RFS). A number of groups and some governors seem to believe that the RFS is a substantial part of the equation when it comes to grain prices, and waiving the program this year or next will ease the impact of the drought on consumers. There is substantial evidence to the contrary.
October 1 2010
BIO submitted letters to the White House Office of Science and Technology Policy and the Presidential Commission for the Study of Bioethical Issues proposing formation of a federal interagency working group to coordinate all agencies’ approaches to regulating synthetic biology.
January 26 2010
BIO is generally supportive of the referenced draft guidance and considers it an important initial step towards screening both producers and customers.
October 9 2013
The Biotechnology Industry Organization’s (BIO) 2013 Pacific Rim Summit on Industrial Biotechnology and Bioenergy will feature presentations on recent innovations in using synthetic biology for renewable chemicals and algae biofuels.
June 12 2013
The 10th Annual World Congress on Industrial Biotechnology will host the Clean Tech Investor Sessions featuring innovative industrial biotechnology companies selected to present to an elite audience of investors and analysts. 
June 4 2013
The 2013 BIO World Congress on Industrial Biotechnology this June 16-19 in Montreal, Canada at the Palais des congrès de Montréal will mark the event’s 10th anniversary. 
May 30 2013
The industrial biotech sector supports reform of the Toxic Substances Control Act that promotes innovation in renewable chemicals, which consumers can be confident are cleaner, healthier and safer.
May 21 2013
BIO invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers and posters for the 2013 Pacific Rim Summit on Industrial Biotechnology and Bioenergy.